Novel antibiotic may prevent travelers' diarrhea


Rifaximin (Xifaxan, Salix), the first nonsystemic, gastrointestinal-selective oral antibiotic to receive approval for the treatment of travelers' diarrhea, is also an effective prophylaxis for travelers' diarrhea, according to data released at Digestive Disease Week in New Orleans.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.